Background -Aural cholesteatomas, also called tympanokeratomas, are destructive and expansile growths of keratinizing epithelium that develop in the middle ear. They have been reported sporadically in dogs, and surgery is usually the recommended treatment.
Introduction
Aural cholesteatoma is an epidermoid cyst that develops in the middle ear and is composed of keratin debris surrounded by keratinizing stratified squamous epithelium. [1] [2] [3] It has been colloquially described as "skin growing in the wrong place". [4] [5] [6] The misplaced keratinizing epithelium constantly sheds keratin debris, resulting in gradual enlargement of the cyst and the eventual destruction of the adjacent tissue due to increasing pressure and osteoclastic bone resorption activated by inflammatory chemokines. 7 In dogs, cholesteatoma is regarded as a severe complication of otitis media. 4 The term tympanokeratoma has also been proposed for this condition. 5 The clinical signs of cholesteatoma in dogs may be nonspecific, including otic discharge, head shaking, rubbing and otic pain. 1, 6 Nasopharyngeal and/or neurological signs also may occur. 1, 3, 7, 8 In humans, early diagnosis of cholesteatoma depends on its identification with otoscopic examination. 9 In veterinary medicine, otoscopy is used to diagnose the condition, 2,10-12 although definitive diagnosis requires histopathological examination. 1, 4 Computed tomography (CT) and magnetic resonance imaging (MRI) are considered to be reliable methods for evaluating the middle ear and demonstrating middle ear-related lesions. 13, 14 CT is utilized to better define bony structures and can yield valuable information for the detection of cholesteatoma. 15 MRI is used for more accurate assessment of soft tissue structures and can be a useful tool for the further characterization of soft tissue changes and recognition of potential complications; 13, 14 however, it is not routinely utilized in part because of the relatively high cost.
The only curative treatment for canine cholesteatoma reported to date is surgery with total ear canal ablationlateral bulla osteotomy (TECA-LBO) and ventral bulla osteotomy. 1, 2, 10, 16 The prime objective of surgery for cholesteatoma is to remove all keratinous debris and stratified squamous epithelium; 17 recurrence postsurgery is common in animals. [1] [2] [3] To the best of the authors' knowledge, 15 reports (covering a total of 70 cases) of canine cholesteatoma have been published. [1] [2] [3] [4] [5] [6] [7] [8] 10, 13, 15, 16, [18] [19] [20] Reports in which the diagnosis of cholesteatoma was confirmed by histopathological evaluation in combination with CT and MR imaging are limited. 1, 8 No clinical studies of nonsurgical management for aural cholesteatoma have been reported. The purpose of the present study was to report the main clinical and imaging findings of aural cholesteatoma; and to report on the long-term outcome of a minimally invasive therapeutic approach in 11 dogs.
Methods and materials Case selection and clinical analysis
Medical records of dogs diagnosed with cholesteatoma, presented between January 2012 and 2018 at the Synergy Animal General Hospital, Saitama, Japan, were examined to determine the following: (i) if histopathological reports stated the presence of keratinizing epithelium and/or thick lamellar keratin debris in the middle ear; (ii) if CT and/or MRI scanning were performed to identify middle ear disease; (iii) if trans-canal endoscopic procedures (TEPs) under anaesthesia were carried out to remove debris in the middle ear; and (iv) if a minimum follow-up of 12 month duration was possible. Signalment, history, physical examination, video-otoscopy findings, diagnostic imaging, cytological evaluation, aerobic microbial culture results, histopathological features and treatment were reviewed in each case. Dogs were followed up and the outcomes of dogs that did not remain in our direct care were determined by telephone interview between the referring veterinarian and client.
Video-otoscopic examination
Ear canal evaluations using a video-otoscope (Karl Storz GmbH & Co. KG; Tuttlingen, Germany, and/or Asuka Medical Inc.; Kyoto, Japan) were conducted both before and during TEPs. An initial examination was performed in conscious dogs to assess if the ear canal was adequately open to enable TEP. If stenosis of the ear canal -due to inflammation and proliferative tissue -blocked otoscope access, topical and/or oral steroids were administered to expand the canal before TEP.
Imaging with CT/MRI was performed with general anaesthesia. The middle ear and ear canal were evaluated using the video-otoscope and/or a 2.7-mm diameter, zero degree rigid endoscope (Asuka Medical Inc.). To facilitate visualization, the ear canal was lavaged using 3-5f feeding tubes with neutral electrolyzed water (NEW) (Asahi Pretec Corp.; Kobe, Japan).
Diagnostic imaging methods
Computed tomography scanning was performed under general anaesthesia with Somatom Emotion 16 (Siemens Healthineers Japan; Tokyo, Japan) to investigate the whole skull. Contiguous transverse 1 mm images were obtained before and after intravenous (i.v.) administration of 2.5 mL/kg (612.4 mg/mL) Iopamidol (Oypalomin 300 injection syringe, Fuji Pharma; Toyama, Japan) and were reconstructed using bone and soft tissue algorithms.
Magnetic resonance imaging was subsequently performed using Magnetom Essenza 1.5T (Siemens Healthineers Japan). Sagittal T2-weighted [T2W; slice thickness = 3.0 mm, repetition time (TR) = 4,000 ms, echo time (TE) = 91 ms], transverse T2W (slice thickness = 3.5 mm, TR = 4,000 ms, TE = 86 ms), dorsal T2W (slice thickness = 3.0 mm, TR = 4,000 ms, TE = 86 ms), transverse fluid-attenuated inversion recovery (FLAIR; slice thickness = 3.5 mm, TR = 8,500 ms, TE = 104 ms, Inversion time = 2,438.7 ms), transverse T1-weighted (T1W; slice thickness = 3.5 mm, TR = 520 ms, TE = 11 ms) and dorsal T1W (slice thickness = 3.0 mm, TR = 500 ms, TE = 12 ms) were acquired. Additional transverse and dorsal T1W were obtained following i.v. administration of 0.2 mL/kg (0.5 mmol/mL) gadodiamide hydrate (Omniscan 32% i.v. injection syringe, Daiichi-Sankyo; Tokyo, Japan).
TEP for cholesteatoma
The TEP was performed in combination with CT and/or MRI examination. Preoperatively, the length, width and depth of the ear canal and middle ear cavity were measured, as well as the distance from the dorsal fold of the ear canal to the tympanic bulla on each CT/MR image of the cases. The dorsal fold (also called auricular projection) by the cartilaginous ridge represents a landmark that separates the vertical and horizontal ear canals. 21 In addition, the type, number, structure, size and distribution of aural lesions were investigated to clarify the anatomical position of lesions within the ear canal. Dogs were positioned in lateral recumbency with the affected side uppermost. Cleaning and flushing the ear canal were conducted with NEW, and any type of obstruction in the external ear canal was removed to access the middle ear. If a protruding nodule in the horizontal ear canal was present, it was grasped with curved mosquito forceps or aural forceps under endoscopic visualization and then removed by a traction-torsion manoeuvre. Residual portions of the nodule were completely removed under endoscopic visualization using 5f biopsy forceps with c.2.5 mm oval cups (Karl Storz GmbH & Co. KG), or vaporized by DLV-20 diode laser (Asuka Medical Inc.). Local irrigation with NEW was used to reduce and control the bleeding. In addition, for cases with stenosis due to proliferative lesions at the bony part of the ear canal, the top of the lesion was vaporized with a diode laser in the same manner as for ablation of residual mass fragments. For all cases, keratinaceous debris was directly removed from the middle ear using the 5f biopsy forceps and samples were placed in 10% formalin for histopathological evaluation separately from the tissues removed from the external ear canal. Impacted keratinaceous debris in the tympanic cavity was then removed by either aural forceps, suction and/or 3-5f feeding tubes under either video-otoscopic or rigid endoscopic guidance. The bulla was lavaged to remove remaining debris with NEW. Finally, 0.1 mL triamcinolone acetonide (Kenacort-A intradermal and intra-articular aqueous suspension infection, 1%, 50 mg/5 mL, Bristol-Myers Squibb; Tokyo, Japan) was administered to the middle ear cavity.
For prophylactic medical management post-TEP, repeated in-clinic tube flushing by a soft feeding tube with NEW was performed in awake dogs once weekly for two to four weeks, followed by tapering to once every two weeks for four weeks and eventually to once monthly. The indication for tapering was based on otic conditions, such as the presence of ear discharge and behaviours including scratching or head shaking. Additionally, routine home cleaning was performed with an ear cleaner (Zymox â ear cleanser, Pet King Brands, Inc.; Westmont, IL, USA), and/or Tromethamine-EDTA (Triz-EDTA Plus â , Dechra; Overland Park, KS, USA) and topical mometasone furoate (Fulmeta â , Shionogi & Co., Ltd.; Osaka, Japan) was applied to the dogs as prophylactic management to control canal inflammation. At-home ear cleaning and topical steroid administration was performed once daily for two to four weeks, tapering to once every two days for four weeks, then once to twice weekly. If otitis flared despite prophylactic flushes with NEW and topical steroid drops, dogs were treated with topical and/or systemic antimicrobials determined by clinician preference based on cytological evaluation and culture results.
Ear cytological evaluation and bacterial cultures
Under general anaesthesia, otic exudate was collected from either the middle ear or the deepest part of the ear canal with 3-5f feeding tubes under video-otoscopic guidance as cytological samples and sterile culture swabs. For cytological evalution, samples were placed onto sterile slides. Then, slides were stained with Microscopic Hemacolor â Rapid staining of blood smear (Merck KGaA; Darmstadt, Germany). Each slide was evaluated under a high-power field (940 and/or 100) for the presence of cocci bacteria, rod-shaped bacteria, keratinized squamous epithelial cells and inflammatory cells. For aerobic bacterial culture and antimicrobial susceptibility testing, swabs were submitted to a diagnostic laboratory (LSI Medience Corporation; Tokyo, Japan). Swabs were inoculated onto sheep blood agar plates which were incubated at 35°C for 24 h. All isolates were identified phenotypically and biochemically. Antimicrobial susceptibility was performed using the broth microdilution method, which determined the minimum inhibitory concentrations of antimicrobial agents according to Clinical and Laboratory Standards Institute guidelines. 22 
Histopathological diagnosis of aural cholesteatoma
Biopsy specimens were fixed in 10% neutral-buffered formalin. Representative trimmed tissues were routinely processed, embedded in paraffin, sectioned at 5 lm and stained with haematoxylin and eosin.
The following criteria were used for diagnosis of cholesteatoma: (i) origin of tissue confirmed as the middle ear using the endoscopic procedure; (ii) presence of cornified epithelium and (iii) presence of amorphous thick lamellar keratin debris. [1] [2] [3] A tentative diagnosis of cholesteatoma also was made for cases which satisfied (i) and (iii) but not (ii) (i.e. they lacked cornified epithelium).
Results

Signalment and clinical findings
Eleven dogs were included in this study; including French bulldog (n = 5); pug (n = 2), and one each of Chihuahua, Yorkshire terrier, shiba inu and Akita inu. There were two intact males, four castrated males and five spayed females. Ages ranged from 4 to 12 years, with a mean age of 8.2 years (median, 8 years). The durations of clinical signs varied from four to 104 weeks, with a mean duration of 28.1 weeks (median 12 weeks). Two dogs had bilateral disease, and nine dogs had unilateral disease, giving a total of 13 ears. Nine of the 11 dogs had a history of chronic otitis externa in the affected ears. Five of the nine dogs had a history of recurrent otitis, and four of nine had a history of continuous otitis. Suspected primary causes of otitis externa were atopic dermatitis (two dogs), excessive cerumen (two dogs), foreign body (two dogs) and idiopathic (four dogs). The duration of chronic otitis externa ranged from six months to over five years. Onset of otitis media was suspected from one to 11 months before their presentation. Two of the 11 dogs had no history of chronic otitis externa and were presented for nasopharyngeal and/or neurological signs of possible middle ear disorders.
Aural signs included otorrhoea (eight dogs), ear scratching (two dogs) and head shaking (two dogs). During physical examination, neurological signs were identified in nine dogs. Head tilt was present in seven dogs, facial nerve paralysis in four dogs and ataxia in three dogs. Two dogs were reported to have had nystagmus, and one dog was said to have had a seizure, but these signs were not detectable at admission. Two dogs showed an algesic response on palpation of the bulla and temporomandibular joint. Two dogs had increased respiratory noise and/or inappropriate respiratory effort. Concurrent diseases were hypothyroidism (two dogs), spondylopathy (two dogs), pyoderma, urolithiasis, cardiological disease (AVblock), entropion, osteoarthritis and patella luxation (one dog each). Details are reported in Table 1 .
Video-otoscopic findings
In 13 ears, video-otoscopy revealed otic discharge and the TM was not observed. In seven ears (cases 1, 2, 3, 4, 5, 10 and 11) a smooth-surfaced, whitish to pale-pinkish and rounded protruding nodule was detected, occluding the horizontal ear canal ( Figure S1 in Supporting Information; Table 1 ). In four ears (cases 3, 4, 8 and 9), a narrowed horizontal ear canal was observed (Table 1) .
Diagnostic imaging findings
Computed tomography
Computed tomography imaging was performed in 10 dogs (12 ears). All dogs had soft tissue-like material within the affected tympanic bullae. Absence of air contrast within the middle ear cavity was observed in all affected ears. Enlargement of the middle ear cavity was identified in seven ears, osteoproliferation in seven, lysis of the bulla in six, lysis of the cochlea in six (Figure 1a) , sclerosis of the temporal bone in two and mineralization of the inner lining of the bulla in one.
Four ears, in two pugs and two French bulldogs, were affected by lysis of the petrous temporal bone and bulla expansion was present in three of four ears. Conversely, all dogs (five ears) without expansion of the bulla also were French bulldogs and only one of five had bulla lysis. Only one (Akita inu) of three nonbrachycephalic dogs had both expansion and lysis of the tympanic bulla wall.
Soft tissue-like material occupying the horizontal ear canal was observed in seven ears. In five of the seven ears, linear mineralization within the soft tissue-like material in the external ear canal was observed ( Figure 1b) and four of seven ears had bulla osteoproliferation. Enlargement of associated lymph nodes was observed in seven dogs (seven ears), specifically the submandibular lymph nodes, retropharyngeal lymph nodes and parotid lymph node in five, six and one dogs, respectively.
Postcontrast CT images were available for two ears. In the images after administration of contrast medium, there was no appreciable contrast enhancement of the tympanic bulla content in either ear. One of the two had an enhancing soft tissue mass occluding the horizontal canal.
Magnetic resonance imaging
Magnetic resonance imaging was performed in all dogs (13 ears). It revealed the presence of material within the bulla which was isointense to slightly hyperintense relative to brain tissue in 12 ears (Figure 2a ) and heterogeneous hyperintense in one ear on T1W images. The mass was heterogeneous hyperintense in nine ears, homogeneous hyperintense in three ears and heterogeneous hypointense in one ear on T2W (Figure 2b ) and FLAIR images (Figure 2c) . Following contrast administration, contents of the bulla did not enhance in all but one ear. However, the inner lining of the bulla showed some partial enhancement in 11 ears. In addition, contrast enhancement of cochleae was observed in nine ears. Heterogeneous contrast enhancement of the meninges also was observed with severe lysis of the petrous temporal bone in two dogs.
In eight ears, soft tissue-like material in the external ear canal was enhanced (Figure 2d ). Before the injection of contrast medium, the material was isointense to brain tissue in all ears on T1W images, whereas it was heterogeneous hyperintense in five ears, slightly hypointense in two ears and hyperintense in one ear on T2W and FLAIR images.
Cytological evaluation and microbial culture Cytological examination of otic discharge was performed in seven ears. Bacterial cocci, rods or a combination of both, were present in four, one and two of seven ears, respectively. Keratinized squamous epithelial cells and neutrophils were identified in four and six of seven ears, respectively. Aerobic bacterial culture of the middle ear was performed in five ears, and all cultures were positive. More than one species of organism was isolated in three ears. Bacteria isolated were Pseudomonas aeruginosa (four of seven ears), group G Streptococcus spp. (two of seven ears), Staphylococcus pseudintermedius group (one of seven ears) and Staphylococcus schleiferi (one of seven ears).
Histopathological findings
Tissue samples taken from 10 middle ears demonstrated keratinizing epithelium and keratin debris consistent with cholesteatoma ( Figure 3 ). In the other three middle ears (cases 6, 8 and 11), a tentative diagnosis of cholesteatoma was made because cornified epithelium was not identified.
In seven dogs, histopathological evaluation of protruding nodules within the external ear canal (Figure 4 ) revealed dense fibrous connective tissue surrounded by squamous epithelium. In addition, five of seven had variable degrees of central cores of osseous metaplasia (OM). In Case 1, a markedly abnormal bony architecture was found.
In one of seven ears, histopathological results for a tissue sample taken from the deeper part of the external acoustic meatus exhibited hyperplasia and hyperkeratosis of the epidermis, dermal oedema, fibrosis and lymphocytic infiltration with dilation of ceruminous glands with stasis of secretum.
Outcome of TEP All dogs, except for Case 6, were discharged with pain medication as a postprocedure in TEP. The duration of pain medication varied from one to five weeks. One dog (Case 5) was given Robenacoxib (Onsior â , Elanco Japan K.K.; Tokyo, Japan) 2.0 mg/kg orally (p.o.) once daily. Eight dogs were administered prednisolone (Predonine â , Shionogi & Co., Ltd.; Osaka, Japan) 0.5-1.0 mg/kg p.o. once daily and one dog (Case 4) was given prednisolone 0.5-1.0 mg/kg p.o. once every other day; then the corticosteroid treatment was tapered down. No serious postprocedural complications were observed in any dogs, except for Case 3 which developed temporary facial nerve paralysis that spontaneously resolved within eight weeks.
Follow-up ranged from 12 to 58 months, with a median follow-up of 29 months (mean, 27.9 months). Post-TEP, in-clinic tube flushing and at-home ear cleaning were performed for all the cases once weekly and once daily, respectively. The frequency of treatment was gradually tapered based on assessment of clinical signs; maintenance treatment of once monthly or twice monthly tube flushing in clinic was performed for six and five dogs, respectively. Routine regular home cleaning was recommended once weekly in five dogs, every other day in one dog and every day in two dogs. The owner of Case 4 declined to continue home cleaning due to difficulties in performing the procedure alone, but monthly in-clinic flushes continued. For all but one dog (Case 4), at-home and in-clinic management continued until the end of the study. In seven ears, glucocorticoid eardrops were applied as a proactive therapy. Initially, three to five drops were applied to each ear once daily. The frequency of administration of topical glucocorticoids was tapered by one half each week to a maintenance frequency of once or twice weekly. For management of chronic aural inflammation, in addition to topical steroid drops, oral oclacitinib was administered to Case 11 after the second TEP and to Case 10 beginning four weeks after the first TEP. For control of concurrent atopic dermatitis, oclacitinib (Apoquel, Zoetis; Parsippany, NJ, USA) was prescribed to Case 9 and oral prednisolone was intermittently administered to Case 6.
Nine ears (seven dogs) had no recurrence of middle ear disease in this study. Four ears (four dogs: cases 3, 4, 5 and 11) had recurrent clinical signs after the first endoscopic procedure. The mean time to recurrence was 4.3 months (range: one to 12 months; median: two months). In Case 3, a protruding nodule recurred two months after the initial procedure, despite the dog receiving prophylactic care. As the owners declined otic surgery, a second TEP was immediately performed, and the dog received systemic and topical antimicrobial medication. Recurrence of cholesteatoma was confirmed with histopathological evaluation. No significant aggravation was observed on either CT or MRI findings, except for osteoproliferation in the bony part of both external ear canals. Clinical signs waxed and waned, and then the dog underwent a third TEP for removal of remnants of keratin debris after which clinical signs resolved. In Case 4, ear discharge recurred at one month after the initial procedure. The owners declined an endoscopic or surgical approach, and the dog was managed with only monthly tube flushing. Unfortunately, clinical signs persisted. In Case 5, ear discharge recurred at 12 months after the initial procedure. Clinical signs waxed and waned, and eventually second TEP was performed due to deterioration of signs 25 months after the first procedure. Recurrence of cholesteatoma was confirmed with histopathological evaluation. No significant changes in CT and MRI findings compared to the first procedure were observed. Clinical signs resolved after the second procedure. In Case 11, otitis recurred two months after the initial procedure. The dog received appropriate home cleaning with administration of oclacitinib. Subsequently, otitis resolved.
None of the owners reported any adverse effects with regard to the management regimen during this study.
Discussion
In the veterinary literature, no significant breed predilection for cholesteatoma has been reported. In this report, over half of the dogs were brachycephalic breeds. Previous reports documented that dysfunction of the auditory tube and the narrow nasopharynx could be predisposing factors for developing primary acquired cholesteatoma. 6, 8 In addition, hypertrophic bulla walls and stenotic bony parts of the horizontal ear canals also could predispose brachycephalic breeds to secondary acquired cholesteatoma. 8 In our study, nine dogs had a history of chronic otitis externa, which can be considered as an important predisposing factor for secondary acquired forms in any breed. 1, 2, 15 However, two of the cases were evaluated for a history of neurological issues, not the typical chronic history of otitis externa. The primary acquired form of cholesteatoma may occur in dogs, although the secondary acquired form appears to be more common.
Computed tomography scanning plays an important role in the assessment of dogs with middle ear diseases. 15, 23 It has been proposed that a nonenhancing but expansile lesion, which is hyper-attenuating to brain, is likely to be a cholesteatoma. 15 However, expansion of the bulla is not regularly observed. 1, 16 Our study identified expansion of the bulla in 53.8% of the ears and 75% of the brachycephalic breeds with expansile bulla also had lysis of the bulla. By contrast, 80% of the brachycephalic breeds without expansile bulla did not have bulla lysis. In humans, it is hypothesized that cholesteatoma slowly enlarges in the middle ear and gradually erodes adjacent bony structures with activated osteoclasts. 24 Thus, the early stages of cholesteatoma might remain unidentified by CT scanning. Bulla expansion in these breeds could be impeded due to their hypertrophic bulla wall.
It was reported, albeit in only one case, that findings on MR imaging included an expansile bulla containing material isointense to brain tissue on T1W and of mixed intensity on T2W images. 13 In addition, material in the bulla was found to show minimal postcontrast enhancement, with enhancement localized to the region immediately adjacent to the bone. 13 In our cases, the bulla contents commonly appeared isointense on T1W images, heterogeneous hyperintense on T2W images and minimally enhanced after contrast injection, with partial enhancement in the location of the inner epithelial lining of the bulla. In humans, the inner component of a cholesteatoma consists of keratin debris that is avascular, 25 so the absence of contrast enhancement of the contents on MR imaging was not unexpected. 1 Furthermore, in humans, vascularity associated with the abnormal epithelium may be increased due to angiogenic growth factors produced by inflammatory cell populations in the matrix and perimatrix of cholesteatoma. 17, 26 Findings of heterogeneous intensity and enhancement on MRI could reflect the histopathological features of cholesteatoma, such as increased vascularity on hyperproliferative epithelium and absent vascularity within keratin debris. Moreover, in humans, it was reported that pre-and postcontrast conventional MRI allows the differentiation of inflammatory mucosa, granulation tissue and cholesteatoma, whereas CT was not able to differentiate between the diseases. 27 Thus, MRI might be a helpful diagnostic tool to ensure accurate and early diagnosis of canine cholesteatoma.
For seven of the 11 dogs in this study, a protruding nodule consisting of fibrous connective tissue surrounded by squamous epithelium was found in the external ear canal. Histopathologically, the lesions in dogs appeared to be different in character from typical aural polyps in cats. Presence of ciliated columnar epithelial cells is a prerequisite for the histopathological definition of a polyp, 28 and as a consequence, in terms of terminology, polyp is not an appropriate description for the canal nodules seen in this study. 19 In dogs, the association between the protruding nodules and cholesteatoma remains to be fully elucidated. [1] [2] [3] [4] [5] [6] [7] [8] 10, 13, 15, 16, [18] [19] [20] It has been reported that a pug with cholesteatoma had an external ear canal mass with a thick, keratinizing epithelium. 8 The authors noted that the lesion might be related to the cholesteatoma. 8 In the present study, histopathological evaluation of external ear canal nodules in five cases revealed a core of OM. Likewise, it has been reported in a German shepherd dog with a cholesteatoma in the middle ear, accompanied by a cholesterol granuloma with a core of OM in the horizontal ear canal. 10 OM is a type of ectopic ossification of fibrous connective tissue. 29 Postoperative short-term complications after TEP occurred in only one dog (9.1%) which developed facial palsy. Procedures involving the middle ear potentially can cause facial nerve palsy and cholesteatoma may be attached to vulnerable underlying structures including the facial nerve. In the veterinary literature, facial nerve palsy and dryness of the nostrils was reported postoperatively in two (18.2%) of 11 dogs that underwent surgery for cholesteatoma. 2 In previous retrospective studies of canine TECA and LBO, 13-46% had facial nerve paresis, [30] [31] [32] and 4-23% had residual deficits in facial nerve function after TECA-LBO. 30, 32, 33 It has been reported that surgical treatment is curative in only 50% of cases of canine cholesteatoma. 1, 12 Recurrence was seen in one of four dogs (25.0%) at 12 months postsurgery in one study and in 10 of 19 dogs (52.6%) at a mean time of 11.3 months in another study. 1, 3 In addition, one study reported that recurrence was suspected in five of 11 dogs (45.5%) at a mean time of 7.5 months. 2 Postsurgical recurrence is likely due to the difficulty of complete surgical removal of abnormal keratinizing epithelium and keratin debris. 6 In the present study, clinical signs recurred in four of 11 dogs (four of 13 ears: 30.8%) at a mean time of 4.3 months post-TEP. For these cases, the involved tissues could not be adequately removed from the middle ear with an initial TEP because of their advanced stage. The remnants of cholesteatoma might lead to recurrence sooner. Moreover, even in cases without recurrence after TEP, the possibility remains that residues of cholesteatoma may persist in small cavities of the bulla and keratin accumulation can slowly create clinical signs. Thus, the need to manage ongoing diseases suggests that owners should be prepared for monitoring after TEP, lifelong maintenance therapy and repeated TEP, if necessary.
As part of maintenance therapy, oclacitinib was used in three cases in this study. In Case 9, oclacitinib was prescribed for concurrent atopic dermatitis. The other two dogs (cases 10 and 11) had unilateral chronic otitis without any cutaneous lesions or identifiable primary disease. Oclacitinib is presumed to inhibit both proallergic and proinflammatory cytokines (IL-2, 4, 6, 13 and 31) as a specific JAK1 and -3 inhibitor. Although it is an extra-label indication, we prescribed oclacitinib to the latter two dogs in an attempt to treat the chronic aural inflammation, which seems to play a fundamental role in multiple aetiopathogenic mechanisms of acquired cholesteatoma. 34 Additionally, it is suggested in humans that the IL-6/ STAT3 signalling pathway is active and may play an important role in the epithelial hyperproliferation of acquired cholesteatoma. 35 During this study, the clinical signs were managed with no relapse in the dogs treated with oclacitinib. More study is necessary to elucidate the efficacy and risk of oclacitinib as a component of postprocedural management in canine cholesteatomas.
In the present study, around 70% of ears were treated successfully by a single TEP, followed by maintenance treatment involving daily to weekly ear cleaning at home and weekly to monthly tube-flushing in the clinic. Likewise, it was reported that the condition in a dog was controlled by removal of keratin debris from the bulla under video-otoscopic guidance, although the dog died from unrelated causes 29 months later. 1 We suggest that conservative treatment of cholesteatoma by TEP with regular removal of the inflammatory stimulus in the middle ear could be useful before or in place of surgery.
Limitations in the evaluation of TEP in this study include its retrospective nature, the small sample size, the referral nature of the population and the lack of objective criteria to define treatment outcome. In the future, a largescale prospective controlled cohort study should be conducted to conclusively evaluate therapeutic outcomes.
In conclusion, chronic otitis externa may not necessarily precede acquired cholesteatoma in dogs but the presence of a protruding nodule in the external canal may be a significant predictor of cholesteatoma and the use of MRI can facilitate the early diagnosis of this disease. Nonsurgical therapy is not curative as surgery may be; however, early conservative treatment of cholesteatoma could be an effective option before or as an alternative to surgery, even though it requires long-term at-home and in-clinic maintenance care. signos de enfermedad del o ıdo medio durante un seguimiento medio de 27,9 meses. Conclusiones e importancia cl ınica -los resultados sugieren que la otitis externa no necesariamente precede al colesteatoma en todos los perros. La MRI parece ser m as sensible que la CT para identificar colesteatomas. El tratamiento conservador de los colesteatomas podr ıa ser util antes o como una alternativa a la cirug ıa. 
Resumo
Contexto -Os colesteatomas aurais, tamb em chamados de timpanoqueratomas, são formac ßões de epit elio queratinizado destrutivas e expans ıveis que se desenvolvem no ouvido m edio. Eles são relatados esporadicamente em cães, e o tratamento cir urgico e geralmente o mais recomendado. Objetivos -Descrever os principais achados cl ınicos, radiogr aficos e histopatol ogicos de colesteatomas e relatar os resultados de tratamentos conservativos. Animais -Onze cães (13 ouvidos) com colesteatomas. M etodos e materiais -Os hist oricos cl ınicos dos cães diagnosticados com colesteatoma entre 2012 e 2018 foram revisados. Todos os cães foram submetidos a tomografia computadorizada (TC) e/ou ressonância magn etica (RM) seguido por procedimento endosc opico trans-canal (TEP) para remoc ßão e coleta de bi opsia das lesões no ouvido m edio. Posteriormente, os cães foram submetidos a limpeza otol ogica na cl ınica inicialmente uma vez por semana e depois mensalmente, bem como limpeza otol ogica em casa e aplicac ßão de formulac ßão otica com esteroide t opico, inicialmente diariamente e depois reduzido para uma a duas vezes por semana. Resultados -Nove cães possu ıam hist orico de otite externa crônica; inclinac ßão de cabec ßa ou paralisia facial foram observadas em sete e quatro casos, respectivamente. O exame otol ogico revelou um n odulo proeminente em sete ouvidos. A TC demonstrou presenc ßa de material similar a tecido mole em 12 bulas e expansão em sete bulas. A RM revelou em 12 ouvidos a presenc ßa de conte udo na bula timpânica que realc ßava minimamente ap os administrac ßão de contraste. Ap os TEP e com o tratamento de manutenc ßão, nove ouvidos não apresentavam mais sinais de otopatia de ouvido m edio por um tempo m edio de acompanhamento de 27,9 meses. Conclusões e importância cl ınica -Os resultados sugerem que a otite externa não necessariamente precede o colesteatoma em todos os cães. A RM parece ser mais sens ıvel que a TC para a identificac ßão de colesteatomas. O tratamento conservativo para colesteatomas pode ser util antes ou como uma alternativa a cirurgia.
